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Abstract 
 
Aim: The aim of our study was to assess the association of carcinoembryonic antigen (CEA) 
and cancer antigen 15-3 (CA15-3) with socio-demographic factors and metastases site in 
women diagnosed with metastatic breast cancer in post-communist Albania.  
Methods: A case-series study was carried out during the period January 2010 – September 
2017 including 110 female patients diagnosed with breast cancer with metastases at the 
Oncology Service of the University Hospital Centre “Mother Teresa” in Tirana, the Albanian 
capital. Of these, 57 (51.8%) patients had evidence of hepatic metastases, whereas the 
reaming 53 (48.2%) patients had metastases in the bones and/or in the lungs. CEA and CA15-
3 were measured at the time of diagnosis for all study participants. In addition, information 
on socio-demographic factors was collected. General linear model was used to assess the 
relationship of CEA and CA15-3 with covariates.      
Results: There was evidence of a significant correlation between CEA and CA15-3 levels 
(Spearman’s rho=0.59, P<0.001). Upon simultaneous adjustment for all covariates, mean 
values of CEA and CA15-3 were significantly higher in patients with metastases in the bones 
and/or in the lungs compared with their counterparts with metastases in the liver. Also, 
CA15-3 levels were significantly higher in younger patients compared with their older 
counterparts. 
Conclusion: This study provides valuable evidence on selected correlates of CEA and CA15-
3 in Albanian female patients diagnosed with metastatic breast cancer. Oncologists and other 
health professionals in Albania, as well as decision-makers and policymakers should be 
aware of the burden and risk factors of breast cancer among women in this transitional 
society.          
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Introduction 
Breast cancer is a serious issue and an important public health problem in all countries 
worldwide. It has been convincingly documented that breast cancer leads to death of more 
women than any other type of malignant tumours (1). A recent systematic review reported 
that, at a global scale, breast cancer is the most frequently diagnosed cancer and the leading 
cause of cancer mortality among women (1). It has been reported that the incidence of breast 
cancer increases by 5% each year in low- and middle-income countries representing an 
increasingly urgent public health problem in these countries, similar to the situation observed 
in higher income countries (1-3). Many studies on this matter have addressed several risk 
characteristics (etiological factors) for breast cancer including reproductive characteristics, 
growth, obesity, and postmenopausal hormones (1,4). Nonetheless, these putative etiological 
factors are responsible only for a small proportion of breast cancer risk (1,4). The prognosis 
of breast cancer depends on a wide range of factors and circumstances including tumour 
biology, histology, peritumoural vascular invasion, tumour size, lymph node involvement, 
receptor status and presence of distant metastasis (5). Furthermore, it has been indicated that 
the skeleton is the most frequent site of metastasis in breast cancer patients (5). 
Cancer antigen 15-3 (CA15-3) and, to a lesser degree, carcinoembryonic antigen (CEA) are 
the tumour markers most strongly related to recurrence in asymptomatic breast cancer 
patients (6,7). Yet, these antigens lack specificity, and the American Society of Clinical 
Oncology (ASCO) does not recommend their use in routine follow-up of patients treated for 
breast cancer (8). In addition, it has been argued that an increase in these tumour markers 
does not predict the number of involved sites or their localization (9). 
According to the Global Burden of Disease (GBD) Study, the mortality rate from breast 
cancer in Albania was estimated at 15.2 deaths per 100,000 females in the year 2016 (10). On 
the other hand, for the same year, the Disability-Adjusted Life Years (DALYs) for breast 
cancer were estimated at about 441 per 100,000 (10). According to the GBD estimates, there 
has been a steady increase in the mortality rate and the burden of breast cancer in Albanian 
women for the period 1990-2010, which was followed by a plateau during the past few years 
(10). However, the validity of such estimates is questionable and open to criticism.    
On the other hand, according to the most recent World Health Organization (WHO) report 
released in 2017 (11), the estimated breast cancer incidence in females in Albania is 30.8 per 
100,000 population. The WHO European Region average is 106.7 per 100,000 population, 
which is substantially higher than in Albania. As a matter of fact, the incidence rate of breast 
cancer in Albanian females is lower than in all countries of the South Eastern European 
region. The highest incidence rate in this region is evident in Slovenia (125.0 per 100,000 
population) followed by Croatia (116.1 per 100,000 population) and Montenegro (114.9 per 
100,000 population) (11). 
In any case, to date, the available scientific evidence about the burden of breast cancer in the 
general female population in Albania is scarce. Likewise, there are no scientific reports about 
the main risk factors or determinants related to breast cancer occurrence among Albanian 
females during the transition period in the past two decades.  
In this framework, the aim of this study was to assess the association between CEA and 
CA15-3 with socio-demographic factors and metastases site in women diagnosed with 
metastatic breast cancer in post-communist Albania, a country characterized by a particularly 
rapid transition towards a market-oriented economy which is associated with tremendous 
changes also in lifestyle patterns of the adult population.   
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Methods  
A case-series study was carried out in Tirana during the period January 2010 – September 
2017. This study involved 110 female patients diagnosed with breast cancer with metastases 
at the Oncology Service of the University Hospital Centre “Mother Teresa” in Tirana, the 
Albanian capital city.  
The different sites of metastases were dichotomized in the current analysis into: liver 
metastases vs. bones and/or lungs metastases.  
CEA and CA15-3 levels were measured for each study participant at the time of diagnosis.   
In addition, a structured questionnaire was administered to all the female patients in order to 
collect information on socio-demographic characteristics including age (which in the analysis 
was dichotomized into: ≤50 years vs. ≥51 years) , district of current residence (dichotomized 
into: Tirana vs. other districts of Albania), place of residence (urban areas vs. rural areas), 
educational attainment (trichotomised in the analysis into: 0-8 years, 9-12 years and ≥13 
years of formal schooling), economic level (also trichotomised into: low, middle, high) and 
employment status (nominal variable: employed, unemployed, retired). 
Spearman’s correlation coefficients were used to assess the association between CEA, CA15-
3, age, and educational attainment (introduced as the number of years of formal schooling). 
On the other hand, general linear model was employed to assess the associations of CEA and 
CA15-3 with socio-demographic characteristic and metastases site of female patients 
diagnosed with metastatic breast cancer. From a methodological point of view, the general 
linear model procedure provides regression analysis and analysis of variance for one 
dependent variable by one or more factors (referred to as variables). Using the general linear 
model procedures one can test the null hypothesis about the effects of other variables on the 
means of various groupings of a single dependent variable. In the current analysis, this 
feature of the general linear model was used in order to compare the mean values of CEA and 
CA15-3 by different categories of socio-demographic factors (age-group: ≤50 years vs. ≥51 
years; district of residence: Tirana vs. other districts of Albania; place of residence: urban vs. 
rural areas; educational level: 0-8, 9-12, ≥13 years; economic lev el: low, middle, high; 
employment status: employed, unemployed, retired) and metastases site (liver vs. bones 
and/or lungs). Initially, age-adjusted mean values and their respective 95% confidence 
intervals (95%CIs) were calculated. Subsequently, multivariable-adjusted (simultaneous 
adjustment for: age-group, district of residence, place of residence, educational attainment, 
income level, employment status and metastases site) mean values and their respective 
95%CIs were calculated.  
SPSS (Statistical Package for Social Sciences, version 17.0), was used for all the statistical 
analyses. 
 
Results  
Overall, mean age of the study population was 57.1±11.9 years (median age: 57.5 years; 
interquartile range: 48.0-66.0 years; age range: 26-83 years).  
Of 110 women included in this study, 57 (51.8%) patients had evidence of hepatic 
metastases, whereas the reaming 53 (48.2%) patients had metastases in the bones and/or in 
the lungs.  
On the whole, 38% of participants had a low educational level; about 32% reported a low 
economic level; and 36% of participants were unemployed (data not shown in the tables).        
Table 1 presents the distribution of CEA and CA15-3 levels in the sample of female patients 
with breast cancer included in this study.  
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Mean (SD) value of CEA was 19.1±23.9 ng/ml (median value: 12.9 ng/ml; interquartile 
range: 4.7-22.1 ng/ml).  
On the other hand, mean (SD) value of CA15-3 was 167.2±205.2 U/mL (median value: 94.7 
U/mL; interquartile range: 27.5-219.5 U/mL). Of note, both CEA and CA15-3 values 
displayed a highly skewed distribution as evidenced in Table 1 by their respective measures 
of dispersion (that is standard deviation).     
 
Table 1. Distribution of CEA and CA15-3 in the study population  
 
PARAMETER  CEA (ng/ml) CA15-3 (U/mL) 
Mean (±SD)  19.1±23.9 167.2±205.2 
Median (IQR)   12.9 (4.7-22.1) 94.7 (27.5-219.5) 
Range  1.7-133.2 6.1-1026.0 
 
There was evidence of a significant correlation between CEA and CA15-3 levels 
(Spearman’s rho=0.59, P<0.001) [Table 2]. Furthermore, there was evidence of a significant 
inverse linear association between CA15-3 and age (rho= - 0.43, P<0.001), but a positive 
relationship with education which was only borderline statistically significant (rho=0.42, 
P=0.1).  
Interestingly, there was a significant inverse correlation between age and educational 
attainment (rho= -0.52, P=0.02).    
 
Table 2. Correlational matrix of CEA, CA15-3 and socio-demographic characteristics 
 
VARIABLE CEA CA15-3 Age 
CA15-3 0.59 (<0.001)* - 
- 
Age   -0.04 (0.704) -0.43 (<0.001) 
Years of formal schooling   0.36 (0.109) 0.42 (0.097) -0.51 (0.023) 
 
* Spearman’s correlation coefficients and their respective p-values (in parentheses).  
 
 
Table 3 presents the association between CEA and socio-demographic characteristics and 
metastases site. In age-adjusted general linear models, there was evidence of a borderline 
statistically significant association of CEA with age-group (mean CEA level was higher 
among younger participants) and district of residence (mean CEA level was lower among 
Tirana residents).  
Furthermore, mean CEA level was higher among the low-educated female patients compared 
with their high-educated counterparts (overall P=0.06). In particular, mean CEA level was 
considerably higher in patients with metastases in the bones and/or lungs compared with 
those with metastases in the liver (27.2 ng/ml vs. 13.5 ng/ml, respectively; P<0.01).  
Upon simultaneous adjustment for all covariates, there was no evidence of significant 
associations of CEA with any socio-demographic factors, whereas the strong and significant 
relationship with metastases site persisted (mean CEA level was 24.5 ng/ml in patients with 
bones and/or lungs metastases compared with 11.9 ng/ml in those with liver metastases; 
P<0.01). 
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Table 3. Association of CEA with socio-demographic characteristics and metastases site; age-
adjusted and multivariable-adjusted mean values from the General Linear Model  
 
 
* This model was simultaneously adjusted for age-group (≤50 years vs. ≥51 years), district of residence (Tirana 
vs. other districts of Albania), place of residence (urban vs. rural areas), educational level (0-8, 9-12, ≥13 years), 
economic level (low, middle, high), employment status (employed, unemployed, retired) and metastases site 
(liver vs. bones and/or lungs).   
 
† Overall p-values and degrees of freedom (in parentheses). 
 
Table 4 presents the association between CA15-3 and socio-demographic characteristics and 
metastases site. In age-adjusted general linear models, there was an inverse and statistically 
significant association of CA15-3 with the age and educational attainment of study 
participants (mean CEA level was higher among the younger and the low-educated 
individuals). In addition, mean CA15-3 level was significantly higher in patients with 
metastases in the bones and/or lungs compared with those with metastases in the liver (235.7 
U/mL vs. 150.4 U/mL, respectively; P<0.01). In multivariable-adjusted general linear 
models, there was evidence of a significant association of CA15-3 with the age-group (mean 
level was 246.6 U/mL in younger patients compared with 84.9 U/mL of their older 
counterparts; P<0.01) and metastases site (mean level was 203.6 U/mL in patients with bones 
and/or lungs metastases compared with 128.0 U/mL in those with liver metastases; P=0.04) 
[Table 4].  
 
VARIABLE 
Age-adjusted Multivariable-adjusted* 
Mean  95% CI P Mean  95% CI  P 
Age-group: 
≤50 years  
≥51 years  
 
24.3 
16.0 
 
17.0-31.6 
10.4-21.7 
 
0.081 
 
20.7 
15.7 
 
10.9-30.4 
8.8-22.6 
 
0.401 
District of residence: 
Tirana  
Other districts  
 
18.7 
21.2 
 
11.3-26.0 
15.2-27.1 
 
0.072 
 
15.6 
20.8 
 
7.3-23.8 
13.8-27.8 
 
0.267 
Place of residence: 
Urban areas  
Rural areas  
 
17.9 
23.8 
 
12.1-23.7 
16.5-31.1 
 
0.206 
 
17.4 
18.9 
 
10.3-24.5 
10.5-27.4 
 
0.759 
Education: 
0-8 years    
9-12 years  
≥13 years   
 
26.4 
18.3 
11.2 
 
19.1-33.7 
11.7-24.9 
0.3-22.2 
0.056 (2)† 
0.068 
0.615 
- 
 
24.6 
18.1 
11.9 
 
15.2-33.9 
5.0-31.3 
0.5-23.3 
0.247 (2) 
0.268 
0.877 
- 
Economic level: 
Low   
Middle  
High     
 
24.7 
18.1 
16.2 
 
16.8-32.7 
12.0-24.3 
2.8-29.6 
0.363 (2) 
0.628 
0.991 
- 
 
18.8 
17.8 
18.0 
 
8.4-29.2 
8.1-27.5 
2.6-33.3 
0.991 (2) 
0.994 
0.997 
- 
Employment status: 
Employed    
Unemployed   
Retired      
 
20.9 
21.7 
16.8 
 
12.7-29.1 
14.1-29.3 
7.0-26.7 
0.716 (2) 
0.913 
0.805 
- 
 
21.3 
18.8 
14.4 
 
12.9-29.7 
10.4-27.3 
3.4-25.4 
0.607 (2) 
0.691 
0.846 
- 
Site of metastases: 
Liver   
Bones and/or lungs  
 
13.5 
27.2 
 
7.4-19.6 
20.9-33.5 
 
0.002 
 
11.9 
24.5 
 
4.3-19.6 
16.9-32.0 
 
0.008 
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Table 4. Association of CA15-3 with socio-demographic characteristics and metastases site; age-
adjusted and multivariable-adjusted mean values from the General Linear Model  
 
 
* This model was simultaneously adjusted for age-group (≤50 years vs. ≥51 years), district of residence (Tirana 
vs. other districts of Albania), place of residence (urban vs. rural areas), educational level (0-8, 9-12, ≥13 years), 
economic level (low, middle, high), employment status (employed, unemployed, retired) and metastases site 
(liver vs. bones and/or lungs).   
 
† Overall p-values and degrees of freedom (in parentheses). 
VARIABLE 
Age-adjusted Multivariable-adjusted* 
Mean  95% CI P Mean  95% CI  P 
Age-group: 
≤50 years  
≥51 years  
 
289.9 
94.2 
 
233.3-346.4 
50.6-137.8 
 
<0.001 
 
246.6 
84.9 
 
170.1-323.1 
31.2-138.7 
 
0.001 
District of residence: 
Tirana  
Other districts  
 
188.7 
194.2 
 
131.9-245.5 
148.2-240.3 
 
0.881 
 
153.9 
177.8 
 
89.1-218.7 
123.1-232.3 
 
0.519 
Place of residence: 
Urban areas  
Rural areas  
 
177.8 
214.9 
 
132.9-222.7 
158.4-271.4 
 
0.303 
 
161.7 
169.9 
 
106.1-217.3 
103.6-236.1 
 
0.834 
Education: 
0-8 years    
9-12 years  
≥13 years   
 
235.6 
184.6 
113.5 
 
179.5-291.7 
133.8-235.5 
29.3-197.6 
0.055 (2)† 
0.052 
0.388 
- 
 
220.2 
150.8 
126.4 
 
146.9-293.6 
47.8-253.7 
37.1-215.6 
0.249 (2) 
0.314 
0.982 
- 
Economic level: 
Low   
Middle  
High     
 
219.9 
186.8 
129.6 
 
158.8-281.1 
139.7-234.0 
26.2-233.1 
0.323 (2) 
0.360 
0.672 
- 
 
171.2 
194.2 
132.0 
 
89.7-252.8 
118.2-270.1 
11.7-252.2 
0.733 (2) 
0.926 
0.818 
- 
Employment status: 
Employed    
Unemployed   
Retired      
 
197.1 
207.1 
163.0 
 
134.0-260.1 
148.3-265.9 
87.3-238.7 
0.637 (2) 
0.893 
0.719 
- 
 
189.8 
177.5 
130.1 
 
124.3-255.2 
111.3-243.7 
43.8-216.5 
0.506 (2) 
0.620 
0.680 
- 
Site of metastases: 
Liver   
Bones and/or lungs  
 
150.4 
235.7 
 
102.5-198.4 
186.6-284.8 
 
0.014 
 
128.0 
203.6 
 
68.0-188.0 
144.7-262.5 
 
0.039 
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Discussion  
Main findings of the current analysis include a higher mean value of both CEA and CA15-3 
levels in Albanian female patients with breast cancer metastases in the bones and/or lungs 
compared with their counterparts with metastases in the liver. Furthermore, mean CA15-3 
level was considerably higher in the younger patients. There was a significant linear 
association between CEA and CA15-3 levels. It should be noted that the current analysis of 
both CEA and CA15-3 values relates to the time of diagnosis and not the subsequent 
treatment which certainly causes alterations of the CEA and CA15-3 values.         
Breast cancer is the most frequent cancer in women from Western countries (9) and it is 
increasing in low- and middle-income countries as well (1-3). In Western countries, the 
incidence of breast cancer has progressively increased in the past 30 years, whereas the 
specific mortality rate is relatively stable (9,12). It has been argued that this is a result of both 
extensive screening and great therapeutic strides (9,13). 
In the current study conducted in Tirana, two important tumour markers were measured in all 
study participants at the time of diagnosis. However, to date, measurement of CA15-3 and 
CEA serum levels are not recommended in the follow-up of breast cancer, in light of their 
lack of specificity (9,14). Yet, some previous studies have indicated that the likelihood of 
discovering recurrence of breast cancer is influenced by the CA15-3 serum level and its 
doubling time (15,16).  
The current analysis may have some limitations related to the inclusion of study participants 
and the data collection procedures. Regarding the possibility of selection bias, it should be 
noted that this study involved all patients with metastatic breast cancer diagnosed and treated 
over a seven-year period at the Oncology Service of the University Hospital Centre “Mother 
Teresa”, which is currently the only tertiary care institution in Albania. Based on this fact, the 
Oncology Service of the University Hospital Centre “Mother Teresa” in Tirana is the only 
public institution in Albania offering specialized services and most of the Albanian female 
patients are assumed to be diagnosed with breast cancer and subsequently treated in this 
medical centre. Therefore, the female patients included in our analysis comprise a 
representative sample of breast cancer patients for the whole period study period. As for the 
possibility of information bias, the diagnosis of breast cancer and the location of metastases 
were based on the best clinical protocols and contemporary examination techniques used in 
other countries. In any case, we cannot entirely exclude the possibility of information bias at 
least for the socio-demographic information which was collected through interviews. Yes, 
seemingly, there is no plausible reason to assume a differential reporting of socio-
demographic factors between women with different clinical characteristics or stage of disease 
progression.  
In conclusion, this study provides valuable evidence on selected correlates of CEA and 
CA15-3 levels in Albanian female patients diagnosed with metastatic breast cancer. 
Oncologists and other health professionals in Albania, as well as decision-makers and 
policymakers should be aware of the burden and risk factors of breast cancer among women 
in this transitional society.  
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